Aurobindo Pharma Limited
AUROPHARMA
Rang în acțiuni
#2074
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Preț acțiune
$17.34
Capitalizare de piață
$9.98B
Schimbare (1 zi)
-3.08%
Schimbare (1 an)
38.71%
Țară
IN
Tranzacționează Aurobindo Pharma Limited (AUROPHARMA)
Categorie
Healthcare
Raport P/S pentru Aurobindo Pharma Limited (AUROPHARMA)
Raport P/S la data de October 2026 TTM: 2.77
Conform celor mai recente rapoarte financiare și prețului acțiunilor Aurobindo Pharma Limited, raportul P/S actual (TTM) este 2.77. La sfârșitul anului 2024, compania avea un P/S de 2.25.
Istoricul raportului P/S pentru Aurobindo Pharma Limited din 2004 până în 2026
Raport P/S la sfârșitul fiecărui an
| An | Raport P/S | Schimbă |
|---|---|---|
| 2026 (TTM) | 2.77 | 33.31% |
| 2025 | 2.08 | -7.36% |
| 2024 | 2.25 | 82.40% |
| 2023 | 1.23 | -26.44% |
| 2022 | 1.68 | -20.27% |
| 2021 | 2.10 | 97.49% |
| 2020 | 1.06 | -55.13% |
| 2019 | 2.37 | 10.73% |
| 2018 | 2.14 | -20.47% |
| 2017 | 2.69 | -15.48% |
| 2016 | 3.19 | 7.66% |
| 2015 | 2.96 | 59.79% |
| 2014 | 1.85 | 142.25% |
| 2013 | 0.77 | 0.21% |
| 2012 | 0.76 | -40.71% |
| 2011 | 1.29 | -11.40% |
| 2010 | 1.45 | 342.21% |
| 2009 | 0.33 | -48.77% |
| 2008 | 0.64 | -62.35% |
| 2007 | 1.70 | -24.28% |
| 2006 | 2.25 | 103.16% |
| 2005 | 1.11 | -7.07% |
| 2004 | 1.19 | 0.00% |
Raport P/S pentru companii similare sau competitoare
| Companie | Raport P/S | Diferență raport P/S | Țara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 154.53% |
IN
|
